|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine
Test Code39373
CPT Codes
80307
Includes
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Buprenorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80348, 80362; HCPCS: G0480).
Confirmation includes the following analytes: Buprenorphine, Norbuprenorphine, Naloxone
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Buprenorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80348, 80362; HCPCS: G0480).
Confirmation includes the following analytes: Buprenorphine, Norbuprenorphine, Naloxone
Preferred Specimen
20 mL random urine collected in a clinical drug test transport vial
Minimum Volume
7 mL
Other Acceptable Specimens
Random urine collected in a sterile, leak-proof urine container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Screen: Immunoassay (IA) • Confirmation: Mass Spectrometry (MS)
Setup Schedule
Monday-Saturday Morning
Report available: 3 Days
Report available: 3 Days
Reference Range
| Buprenorphine | <5 ng/mL |
| Buprenorphine | <2 ng/mL |
| Norbuprenorphine | <2 ng/mL |
| Naloxone | <2 ng/mL |
Clinical Significance
Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.
